The penny has dropped well and truely.
3rd quater numbers 2023
Revenue; $1.12m
Staff/Directors Cost: $1.68m
This company has no growth and a slow burn of $1m per quarter untill death. In Australia HIV will be eradicted by 2024 and therefore the HIV product sales in Australia are dead to nothing. The only countries wanting the HIV test are 3rd world countries and they cannot afford to pay for these tests as their are bigger issues to deal with.
I see the company is looking at ways to save in costs but dont mention the elephent in the room the CEO and CFO's salary which is astronomical considering the deficent revenue and no commercial growth prospects at all. I would like to see CEO and CFO reduce their salries by 70% as this will save at least $1m which is equivalent to one quarters revenue.
We only have 8 quarters left at this slow burn to zero.
This company has no growth prospects, no products anyone but 2nd rate partners want on a consignment basis only.
- Forums
- ASX - By Stock
- AT1
- Ann: Quarterly Activity Report - 31 March 2023
Ann: Quarterly Activity Report - 31 March 2023, page-2
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.10M |
Open | High | Low | Value | Volume |
2.0¢ | 2.1¢ | 2.0¢ | $1.244K | 61.94K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 1627919 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 152000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 1627919 | 0.020 |
4 | 765000 | 0.019 |
4 | 462414 | 0.018 |
3 | 65000 | 0.017 |
3 | 333328 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 152000 | 2 |
0.022 | 53184 | 2 |
0.023 | 200000 | 1 |
0.024 | 113559 | 2 |
0.025 | 29000 | 2 |
Last trade - 15.45pm 09/09/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |